Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

Published:2020-09-01 Issue:9 Volume:138 Page:955
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Sahni Jayashree¹,Dugel Pravin U.²³⁴,Patel Sunil S.⁵,Chittum Mark E.⁶,Berger Brian⁷,del Valle Rubido Marta¹,Sadikhov Shamil⁸,Szczesny Piotr¹,Schwab Dietmar¹,Nogoceke Everson¹,Weikert Robert¹,Fauser Sascha¹

Affiliation:

1. Roche Innovation Center Basel, Roche Pharma Research and Early Development, F. Hoffman-La Roche Ltd, Basel, Switzerland

2. Retinal Consultants of Arizona, Phoenix

3. USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles

4. now affiliated with IVERIC bio, New York, New York

5. West Texas Retina Consultants, Abilene

6. Retina Consultants of Southern Colorado, Colorado Springs

7. Retina Research Center, Austin, Texas

8. Roche Product Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2768856/jamaophthalmology_sahni_2020_oi_200054_1599662699.01604.pdf

Reference44 articles.

1. Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration.;Wykoff;J Manag Care Spec Pharm,2018

2. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.;Solomon;Cochrane Database Syst Rev,2019

3. Ten years of anti-vascular endothelial growth factor therapy.;Ferrara;Nat Rev Drug Discov,2016

4. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.;Heier;Ophthalmology,2012

5. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies.;Schmidt-Erfurth;Ophthalmology,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: A systematic review, meta-analysis, and trial sequential analysis;Pharmacological Research;2024-10

2. Faricimab in Previously Treated Eyes With Neovascular Age-Related Macular Degeneration: An Assessment of Durability and Treatment Outcomes;Ophthalmic Surgery, Lasers and Imaging Retina;2024-09

3. Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists;Eye;2024-08-30

5. Efficacy and safety of efdamrofusp alfa versus aflibercept in participants with neovascular age-related macular degeneration: a randomized, double-masked, active-controlled, non-inferiority, phase 2 trial;Ophthalmology Retina;2024-08